Budget Impact Analysis of Niraparib and Olaparub As Maintenance Therapy for Platinum Sensitive, Recurrent Ovarian Cancer In The US

May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.132
https://www.valueinhealthjournal.com/article/S1098-3015(18)30432-7/fulltext
Section Title :
Section Order : 732
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30432-7&doi=10.1016/j.jval.2018.04.132
HEOR Topics :
Tags :
Regions :